AtriCure, Inc. — Director's Dealing 2021

Jun 23, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2021-06-21

Reporting Person: Noznesky Justin J (Chief Mktg & Strategy Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-21	Common Stock	M	15000	$18.30	Acquired	55808	Direct
2021-06-21	Common Stock	S	15000	$76.36	Disposed	40808	Direct
2021-06-21	Common Stock	S	6000	$76.36	Disposed	34808	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-21	Stock Option (right to buy)	$18.30	M	15000	Disposed	2024-01-06	Common Stock (15000)	Direct

Footnotes

F1: These shares were exercised pursuant to a 10b5-1 trading plan.

F2: These shares were sold pursuant to a 10b5-1 trading plan.

F3: This transaction was executed in multiple trades at prices ranging from $74.11 to $77.13 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.